Gómez-Alvarado O, Rodríguez-Covarrubias F, Sotomayor M, Castillejos-Molina R, Gabilondo F, Feria-Bernal G

Language: Spanish
References: 21
Page: 12-17
PDF size: 66.22 Kb.

ABSTRACT

Objective. To assess the prognostic role of clinical and pathological variables in patients with renal-cell carcinoma (RCC) treated surgically. Material and methods. We retrospectively analyzed our database of 394 consecutive patients with renal tumors. We excluded those with hereditary conditions, benign tumors or histological diagnosis other than RCC. The variables evaluated were weight loss, performance status, thrombocytosis, tumor diameter, nuclear grade, lymph node invasion and metastases. The main endpoint was cancer-specific survival (CSS). We performed univariate and multivariate analysis to determine prognostic factors. Results. We identified 345 patients with RCC treated surgically between 1980 and 2009. After a median follow-up of 32 months, 23% died from cancer; they had larger tumors (p ‹ 0.0001), higher nuclear grade (p ‹ 0.0001) and lymphovascular invasion (p ‹ 0.0001). The 5- and 10-year CSS was 97.6 and 97.6% for stage I, 75.3 and 63.8% for stage II; 62.3 and 55.5% for stage III; 16.5 and 11.0% for stage IV (p ‹ 0.0001). All variables were associated with CSS on univariate analysis. On multivariate analysis tumor size, thrombocytosis, nuclear grade, lymph node invasion and metastases were independently associated with cancer-related mortality. Conclusion. Our findings confirm the potential role of tumor size, nuclear grade, lymph node invasion and metastases. Thrombocytosis also has a prognostic role in patients with renal-cell carcinoma.

REFERENCES

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.

2. Aron M, Nguyen MM, Stein RJ, et al. Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 2008; 54: 133-40.

3. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumors. J Pathol 1997; 183: 131-3.

4. Drucker BJ. Renal cell carcinoma: current status and future prospects. Cancer Treat Rev 2005; 31: 536-45.

5. Rodríguez-Covarrubias F, Gabilondo B, Borgen JL, Gabilondo F. Partial nephrectomy for renal tumors using selective parenchymal clamping. Int Urol Nephrol 2007; 39: 43-6.

6. Lam JS, Shvarts O, Leppert JT, et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-62.

7. Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004; 172: 58-62.

8. Janzen NK, Kim HL, Figlin RA, et al. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30: 843-52.

9. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer staging manual, 6th Ed. New York: Springer-Verlag; 2002.

10. Siemer S, Lehmann J, Loch A, et al. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol 2005; 173: 33-7.

11. Srigley JR, Hutter RVP, Gelb AB, et al. Current prognostic factors- Renal cell carcinoma. Cancer 1997; 80: 994-6.

12. Knight DA, Stadler WM. Prognostic factors in localized renal cell cancer. BJU Int 2007; 99: 1212-6.

13. Furniss D, Harnden P, Ali N, et al. Prognostic factors for renal cell carcinoma. Cancer Treat Rev 2008; 34: 407-26.

14. Klatte T, Patard JJ, De Martino M, et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008; 179: 1719-26.

15. Karakiewicz PI, Lewinshtein DJ, Chun FKH, et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 2006; 50: 521-9.

16. Kawata N, Nagane Y, Yamaguchi K, et al. How do symptoms have an impact in the prognosis of renal cell carcinoma? Int J Urol 2008; 15: 299-303.

17. Motzer RJ, Mazumdar M, Bacik J, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999; 17: 2530-40.

18. Rodríguez-Covarrubias F, Castillejos-Molina R, Sotomayor M, et al. The impact of lymph node invasion and sarcomatoid differentiation in the survival of patients with locally advanced renal cell carcinoma. Urol Int 2010; en prensa.

19. Symbas NP, Townsend MF, El-Galley R, et al. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 2000; 86: 203-7.

20. Suppiah R, Shaheen PE, Elson P, et al. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 2006; 107: 1793-800.

21. Rodríguez-Jasso VH, Serrano-Brambila E, Maldonado-Alcaraz E. Factores pronósticos en cáncer renal localizado y localmente avanzado. Actas Urol Esp 2008; 32: 320-4.